Inhaled Insulin and Wireless Glucose Monitoring Trial
October 24, 2017 | Terry Sharrer
One Drop Diabetes Management Platform
The FDA has approved MannKind Corporation’s (West Lake Village, CA) “Afrezza” inhaled insulin, and One Drop’s (New York City) wireless glucose monitoring system, but now the two are working together to see how well the drug and a diet and exercise telehealth program can stabilize glucose levels over time. MORE
Image Credit: MannKind Corporation
